| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |